文献速递外周血管心血管US

超声造影评估冠心病患者颈动脉斑块新生血管

Evaluation of Carotid Plaque Neovascularization in Patients With Coronary Heart Disease on Contrast-Enhanced Ultrasonography.
PubMed 文献 · J Ultrasound Med · 2017-10-13

本研究纳入60例急性冠脉综合征(ACS)患者与60例稳定型冠心病患者,行常规颈动脉超声及超声造影,定量分析斑块增强。ACS组斑块增强比例、峰值信号强度及斑块与颈动脉管腔增强强度比均高于稳定型冠心病组,峰值信号强度诊断ACS的敏感度为80.0%、特异度为88.3%(阈值9.97 dB,AUC 0.865)。作者认为颈动脉斑块增强可能是ACS发生的潜在独立危险因素。

要点

  • ACS组颈动脉斑块增强比例、峰值信号强度及斑块与管腔增强强度比均高于稳定型冠心病组。
  • 峰值信号强度诊断ACS的敏感度80.0%、特异度88.3%,阈值9.97 dB,AUC 0.865。
  • 颈动脉斑块增强可能是ACS发生的潜在独立危险因素。

核心结论

  • 颈动脉斑块增强可能是ACS发生的潜在独立危险因素。
  • 颈动脉斑块易损性与冠状动脉症状状态相关,符合动脉粥样硬化共同发病机制。

研究设计与样本

  • 研究纳入60例ACS患者和60例稳定型冠心病患者,行常规颈动脉超声和超声造影,观察并定量分析斑块增强。
  • ACS发生后1个月内行颈动脉超声造影。
  • 评估测量的观察者间和观察者内变异性。

关键影像表现/征象

  • ACS组软斑块比例为81%,高于稳定型冠心病组的53%。
  • ACS组斑块增强比例、峰值信号强度和斑块与颈动脉管腔增强强度比均高于稳定型冠心病组。
  • 峰值信号强度与高敏C反应蛋白值相关。

诊断标准与关键数值

  • 峰值信号强度诊断ACS的敏感度为80.0%、特异度为88.3%,阈值9.97 dB,受试者工作特征曲线下面积0.865。
  • Logistic回归分析显示年龄(65-74岁)、高敏C反应蛋白和增强强度与ACS发生相关。

临床应用与阅片要点

  • 颈动脉超声造影可定量分析斑块内新生血管,峰值信号强度反映局部微血管密度和毛细血管容量。
  • 时间-强度曲线测量具有良好重复性。
  • 作者认为颈动脉斑块增强可能是ACS发生的潜在独立危险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To examine the repeatability of quantitative time-intensity curve analysis of neovascularization within carotid plaques with contrast-enhanced ultrasonography (US) and to investigate carotid plaque neovascularization in patients with coronary heart disease using contrast-enhanced US and the correlation between risk factors and acute coronary syndrome (ACS).

METHODS: Sixty patients with ACS and 60 with stable coronary artery disease (CAD) underwent conventional carotid and contrast-enhanced US, and plaque enhancement was observed and analyzed quantitatively. Carotid contrast-enhanced US was performed within 1 month of ACS occurrence. Interobserver and intraobserver variability of the measurements was assessed. The peak signal intensity was the maximum number of contrast microbubbles that local tissues could accumulate, reflecting the local microvascular density and representing the capillary volume.

RESULTS: The ACS group had higher low-density lipoprotein cholesterol (mean ± SD, 3.21 ± 0.75 versus 2.53 ± 0.71 mmol/L; P < .01) and high-sensitivity C-reactive protein (CRP; 3.76 ± 0.19 versus 2. 93 ± 0.15 mg/L; P < .01) levels than the stable CAD group. The proportion of soft plaques in the ACS group (81%) was higher than in the stable CAD group (53%). The proportion of plaque enhancement, peak signal intensity, and plaque-to-carotid lumen enhancement intensity ratio were higher in the ACS group than the stable CAD group. The peak signal intensity was correlated with the high-sensitivity CRP value. Logistic regression analyses indicated that age (65-74 years), high-sensitivity CRP, and enhancement intensity were correlated with the occurrence of ACS. The sensitivity and specificity of the peak signal intensity in carotid plaques were 80.0% and 88.3%, respectively (cutoff value, 9.97 dB; area under the receiver operating characteristic curve, 0.865). The time-intensity curve measurements had good repeatability.

CONCLUSIONS: Carotid plaque enhancement is a potential independent risk factor for ACS occurrence. These results illustrate the correlation of carotid plaque vulnerability with the coronary artery symptomatic state according to the common pathogenetic mechanism of atherosclerosis.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Qin C, Zhang L, Wang X, et al. Evaluation of Carotid Plaque Neovascularization in Patients With Coronary Heart Disease on Contrast-Enhanced Ultrasonography. J Ultrasound Med. 2017. PMID: 29027678. doi:10.1002/jum.14410

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。